Stocktoria
ARDELYX, INC. ARDX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-19
ARDELYX, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Williams Laura A | Chief Patient Officer | 2026-06-18 | Option exercise | 31,000 | $0.99 |
| Williams Laura A | Chief Patient Officer | 2026-06-18 | Sell | 81,898 | $5.99 |
| Parsey Merdad | director | 2026-06-16 | Grant | 26,455 | — |
| Rodgers Richard J | director | 2026-06-16 | Grant | 26,455 | — |
| MOTT DAVID M | director | 2026-06-16 | Grant | 20,282 | — |
| MOTT DAVID M | director | 2026-06-16 | Grant | 26,455 | — |
| Cadoret-Manier Onaiza | director | 2026-06-16 | Grant | 26,455 | — |
| Bhanji Muna | director | 2026-06-16 | Grant | 26,455 | — |
Source: SEC EDGAR filings · CIK 0001437402 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.